The Educated Patient: What does it Mean to be Resistant to Botulinum Toxins?

Developing Story: Resistance

What We’re Seeing — and Why It Matters

Over the past six years, we’ve noticed more patients are telling us:

“It doesn’t last like it used to.”

“I feel like I need more units.”

“It’s wearing off faster.”

In most cases, this is not true resistance. Muscle strength, metabolism, dosing patterns, and treatment intervals all influence duration.

But in a small subset of patients, there may be something else at play: immunoresistance due to neutralizing antibodies (NAbs). At Skinfocused, we take a deliberate, evidence-based approach to understanding why this happens — and how to reduce the risk and treat it when necessary.

What Is Botulinum Toxin Resistance?

Neutralizing antibodies can develop in a subset of patients receiving repeated botulinum toxin type A treatments. Across large therapeutic studies (in a variety of different specialties), there is a reported neutralizing antibodies prevalence ranges from approximately 12 to 14%, depending on indication, dose, and formulation.

Importantly, aesthetic patients have historically demonstrated MUCH LOWER rates. However, in patients who experience true secondary treatment failure, approximately half test positive for neutralizing antibodies, suggesting that immunoresistance is real — but not the only explanation for loss of response. Not every shorter result equals resistance. But resistance does exist.

Why Might We Be Seeing More of It?

Several factors may influence antibody formation:

• Higher cumulative lifetime dosing

• Short injection intervals

• Booster injections before prior toxin has worn off

• High-dose therapeutic exposure

Repeated exposure at short intervals appears to increase immunologic risk in susceptible individuals.

As the aesthetic industry has expanded — with more frequent treatments and promotional dosing — cumulative exposure has increased for many patients.

Thoughtful scheduling matters. Good skin should not be rushed.

Not All Treatment Failure Is Immunologic

It is critical to emphasize that all patients disappointed with their results might not have neutralizing antibodies which have rendered the treatment ineffective.

Other explanations for lack of treatment efficacy include:

• Underdosing

• Inadequate muscle targeting

• Dilution variability

• Treating too frequently

• Changing anatomy over time

As a medical practice, we adhere to exacting standards in storage, dilution, and reconstitution to preserve potency and consistency — details that can significantly impact clinical outcomes. Unlike other high-volume aesthetic settings where handling protocols may vary, a board-certified dermatology practice maintains strict medical procedures to safeguard patient outcomes. This is why evaluation and treatment by a board-certified dermatologist matters. Aesthetic medicine is still medicine.

Our Philosophy: Prevent Before You React

Prevention strategies supported by the literature include:

• Avoiding unnecessary booster injections

• Maintaining appropriate treatment intervals

• Using the minimum effective dose

• Considering formulation selection thoughtfully

We do not treat on autopilot.

We thoroughly evaluate and consider.

We intentionally treat fewer patients per day.

We spend more time and more focus on each patient.

The result: better long-term outcomes.

If You Think Your Toxin Isn’t Working

The first step is a thoughtful medical assessment.

We evaluate:

• Your dosing history

• Treatment intervals

• Formulations used

• Response patterns over time

Only after careful analysis do we consider adjustments — whether that means altering dose, extending intervals, or switching within type A botulinum formulations.

In carefully selected patients with suspected resistance, we have recently incorporated Myobloc (rimabotulinumtoxinB), a different serotype, when clinically appropriate. Switching serotypes can provide benefit in true resistance cases, although tolerability and side effect profile are important considerations.

Aesthetic Medicine Is Still Medicine

Botulinum toxin remains one of the safest, most studied medications in the world. True resistance is uncommon in cosmetic patients. Long-term strategy matters.

Expertise stays in demand for a reason. Your skin is worth thoughtful planning.